Certification Rate
93.8%
Moderate DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Waltham, MA NAICS: 541714
U.S. Department of Labor's OFLC discloses 16 Labor Condition Application filings naming Dyne Therapeutics, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 15 H-1B petitions naming Dyne Therapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (15 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Dyne Therapeutics, Inc. is listed in 16 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 93.8% of those LCAs; the median listed offered wage is $183,267. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Waltham, MA.
Dyne Therapeutics, Inc. LCA outcome mix
16DOL LCA filings on record
Dyne Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
16 13444th of 122824 higher than 109,380 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $105,256–$275,000 .
DOL LCA release change
On 16 LCAs with comparable offered vs prevailing wages, Dyne Therapeutics, Inc. averages about 31.6% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (50% of LCA filings).
Only 16 LCAs on file for Dyne Therapeutics, Inc., and 81.3% land in WALTHAM CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 93.8%.
Certification Rate
93.8%
Moderate DOL cert
Avg. Salary
$183,267
Well above portal avg
Total Workers
16
Small worker count
Compensation range for H-1B positions at Dyne Therapeutics, Inc.
Wage vs. DOL Minimum
+31.6%
High vs DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
50% of LCA filings
Full-Time Positions
100%
Primary Worksite County
WALTHAM CITY, MA
81.3% of LCA filings
Most frequently listed job titles at Dyne Therapeutics, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Director, Drug Safety & Pharmacovigilance Scientist | 3 | $236,667 |
| Director, Analytical Development/Quality Control (QC) | 2 | $211,765 |
| Senior Research Associate, RNA Chemistry | 1 | $123,000 |
| Senior Research Associate, Platform Development | 1 | $105,256 |
| Senior Research Associate, CMC Process Sciences | 1 | $116,630 |
| Senior Research Associate | 1 | $114,862 |
| Senior Manager, Analytical Development and Quality Control | 1 | $169,000 |
| Senior Director, Scientific & Medical Education | 1 | $275,000 |
| Senior Director, Regulatory Information Management | 1 | $265,000 |
| Senior Associate, Senior Engineer Information Security | 1 | $120,000 |
| Scientist, Platform Development | 1 | $125,000 |
| Associate Director, Statistical Programming | 1 | $210,000 |
| Associate Director, Clinical Operations Study Lead | 1 | $175,000 |
Cross-state DOL neighbors for Dyne Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (16 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($183,267 here).
Dyne Therapeutics, Inc. is listed in 16 DOL Labor Condition Application filings covering 16 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Dyne Therapeutics, Inc. ranks #12843 by total LCA filing count (16 filings). 109,380 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Dyne Therapeutics, Inc. has a 93.8% DOL certification rate, with 15 out of 16 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Dyne Therapeutics, Inc.'s LCAs is $183,267. Listed wages range from $105,256 to $275,000 and are not verified actual compensation.
The top job titles in Dyne Therapeutics, Inc.'s LCA filing records include Director, Drug Safety & Pharmacovigilance Scientist, Director, Analytical Development/Quality Control (QC), Senior Research Associate, RNA Chemistry. The most common listed title is Director, Drug Safety & Pharmacovigilance Scientist with 3 LCA filings at an average listed offered wage of $236,667. This does not establish actual job openings, hiring, or approved petitions.
Dyne Therapeutics, Inc. is headquartered in Waltham, MA.
No, Dyne Therapeutics, Inc. is not classified as H-1B dependent.
Dyne Therapeutics, Inc. is listed in 1 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $175,000 to $235,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Dyne Therapeutics, Inc.); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Dyne Therapeutics, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Dyne Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 16 LCAs (Δ 0 heavier vs Dyne Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Dyne Therapeutics, Inc.'s MICRO-BOOK.
Open the MA state board after the ABS peers. Dyne Therapeutics, Inc. stamps MICRO-BOOK · CERT-SOLID inside that worksite mix.
Dyne Therapeutics, Inc.'s CERT-SOLID stamp sits below CERT-CLEAN. Start with how LCA certification works.
What to do with this profile
Use the DOL LCA record for Dyne Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.